Drug targeting using low density lipoprotein (LDL): physicochemical factors affecting drug loading into LDL particles. (Q52532374)

2 May 2018

title

Drug targeting using low density lipoprotein (LDL): physicochemical factors affecting drug loading into LDL particles. (English)

1 reference

2 May 2018

1 reference

Kader A

1 reference

2 May 2018

Davis PJ

series ordinal

1 reference

2 May 2018

Kara M

series ordinal

1 reference

2 May 2018

Liu H

series ordinal

1 reference

2 May 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

2 May 2018

Journal of Controlled Release

published in

1 reference

2 May 2018

volume

1 reference

2 May 2018

issue

2-3

1 reference

2 May 2018

page(s)

231-243

1 reference

2 May 2018

Biodegradable microspheres in drug delivery

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Drug-polymer conjugates: potential for improved chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Treatment of cancer patients with a low-density-lipoprotein delivery vehicle containing a cytotoxic drug

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Delivery of lipophilic drugs using lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Lipoproteins as potential site-specific delivery systems for diagnostic and therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

LDL-receptor structure. Calcium cages, acid baths and recycling receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Synthesis of the dioleoyl derivative of iododeoxyuridine and its incorporation into reconstituted high density lipoprotein particles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Sequential flotation ultracentrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Prevention of phospholipase-C induced aggregation of low density lipoprotein by amphipathic apolipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Thermal history alters cholesterol effect on transition of 1-palmitoyl-2-linoleoyl phosphatidylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Synthesis and evaluation of radioiodinated cholesteryl ethers as lipoprotein probes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Plasma lipoproteins as drug carriers: pharmacological activity and disposition of the complex of beta-sitosteryl-beta-D-glucopyranoside with plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Characterization of native and drug-loaded human low density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Doxorubicin in sterically stabilized liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Tumor selective effect of RS-1541 (palmitoyl-rhizoxin) in M5076 sarcoma and host tissues in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Comparative study of the incorporation of ellipticine-esters into low density lipoprotein (LDL) and selective cell uptake of drug--LDL complex via the LDL receptor pathway in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: role of lipid transfer protein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Liposomal formulations of cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Fluorinated phosphatidylcholine-based liposomes: H+/Na+ permeability, active doxorubicin encapsulation and stability, in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Immunoliposomes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Targeted delivery of doxorubicin via sterically stabilized immunoliposomes: pharmacokinetics and biodistribution in tumor-bearing mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

Development of anti-p185HER2 immunoliposomes for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2898%2900052-2

7 January 2021

10.1016/S0168-3659(98)00052-2

Identifiers

DOI

1 reference

2 May 2018

1 reference

2 May 2018